Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 4/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4465072 | 0.89 | MAPT (0.57) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL8983993 | 0.85 | MAPT (0.48) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL1227819 | 0.85 | SMN1; SMN2 (0.76) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL31186354 | 0.85 | SMN1; SMN2 (0.76) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL4482108 | 0.81 | SMN1; SMN2 (0.66) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL4464671 | 0.79 | SMN1; SMN2 (0.74) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL6266319 | 0.79 | ALDH1A1 (0.57) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL10620423 | 0.79 | ALDH2 (0.79) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL9755698 | 0.78 | ALDH1A1 (0.56) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 | |
| SCHEMBL16458925 | 0.78 | ALDH2 (0.73) | MAPTALDH1A1SMN1; SMN2TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4163746-A | ANABOLIC, 5-METHYL-7-ALKOXYISOFLAVONES | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1979-08-07 | — | — | US | claimed |
| US-7625943-B2 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J | 2009-12-01 | — | — | US | disclosed |
| US-20050065354-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | ROBERTS WILLIAM J (US) | 2005-03-24 | — | — | US | disclosed |
| US-6818668-B2 | ADMINISTERING PRODRUGS OF METABOLITES SUCH AS 5-METHYL-7-ETHYL CARBONATE-ISOFLAVONE, TO INCREASING CONCENTRATION OF FLAVONOIDS | BIOTEST LABORATORIES, LLC | 2004-11-16 | — | — | US | disclosed |
| WO-2003087083-A1 | 5-ALKYL-7-ALKYLCARBONATE-ISOFLAVONE ESTER AS ISOFLAVONE PRODRUG | BIOTEST LABORATORIES, LLC (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030195245-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | BIOTEST LABORATORIES, LLC | 2003-10-16 | — | — | US | disclosed |
| US-20020187179-A1 | Non-steroidal anabolic compositions and associated methods | LIFESMART NUTRITION, INC. | 2002-12-12 | — | — | US | disclosed |
| US-4163746-A | ANABOLIC, 5-METHYL-7-ALKOXYISOFLAVONES | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1979-08-07 | — | — | US | disclosed |
| US-4163746-A | ANABOLIC, 5-METHYL-7-ALKOXYISOFLAVONES | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1979-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020187179-A1 | Non-steroidal anabolic compositions and associated methods | GPR119, IGFBP1, IGFBP5 | MAPT 3541/4885ALDH1A1 4426/4885SMN1; SMN2 1132/4885 |
| US-20030195245-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | CYP2A7, CYP8B1, CYP3A7 | MAPT 4874/4885ALDH1A1 708/4885SMN1; SMN2 2349/4885 |
| US-20050065354-A1 | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | CYP2A7, CYP8B1, CYP3A7 | MAPT 4874/4885ALDH1A1 696/4885SMN1; SMN2 2299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.